Scandion Oncology (Sweden) Buy Hold or Sell Recommendation
| SCOL Stock | SEK 0.07 0 1.43% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Scandion Oncology AS is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Scandion Oncology AS given historical horizon and risk tolerance towards Scandion Oncology. When Macroaxis issues a 'buy' or 'sell' recommendation for Scandion Oncology AS, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Scandion Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Scandion and provide practical buy, sell, or hold advice based on investors' constraints. Scandion Oncology AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Scandion |
Execute Scandion Oncology Buy or Sell Advice
The Scandion recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Scandion Oncology AS. Macroaxis does not own or have any residual interests in Scandion Oncology AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Scandion Oncology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Scandion Oncology Trading Alerts and Improvement Suggestions
| Scandion Oncology generated a negative expected return over the last 90 days | |
| Scandion Oncology has high historical volatility and very poor performance | |
| Scandion Oncology has some characteristics of a very speculative penny stock | |
| Scandion Oncology has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (51.7 M) with loss before overhead, payroll, taxes, and interest of (32.32 M). | |
| Scandion Oncology AS has accumulated about 131.54 M in cash with (49.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Scandion Oncology Returns Distribution Density
The distribution of Scandion Oncology's historical returns is an attempt to chart the uncertainty of Scandion Oncology's future price movements. The chart of the probability distribution of Scandion Oncology daily returns describes the distribution of returns around its average expected value. We use Scandion Oncology AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Scandion Oncology returns is essential to provide solid investment advice for Scandion Oncology.
| Mean Return | -1.09 | Value At Risk | -9.37 | Potential Upside | 7.69 | Standard Deviation | 5.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Scandion Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Scandion Oncology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Scandion Oncology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Scandion Oncology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Scandion stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.93 | |
β | Beta against Dow Jones | -1.48 | |
σ | Overall volatility | 5.24 | |
Ir | Information ratio | -0.23 |
Scandion Oncology Volatility Alert
Scandion Oncology AS exhibits very low volatility with skewness of -0.08 and kurtosis of 1.57. Scandion Oncology AS is a penny stock. Although Scandion Oncology may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Scandion Oncology AS. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Scandion instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Scandion Oncology Fundamentals Vs Peers
Comparing Scandion Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Scandion Oncology's direct or indirect competition across all of the common fundamentals between Scandion Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Scandion Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Scandion Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Scandion Oncology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Scandion Oncology to competition |
| Fundamentals | Scandion Oncology | Peer Average |
| Return On Equity | -0.74 | -0.31 |
| Return On Asset | -0.42 | -0.14 |
| Operating Margin | 473.28 % | (5.51) % |
| Current Valuation | (6.85 M) | 16.62 B |
| Shares Outstanding | 40.71 M | 571.82 M |
| Shares Owned By Insiders | 1.82 % | 10.09 % |
| Price To Book | 1.01 X | 9.51 X |
| Price To Sales | 969.63 X | 11.42 X |
| Gross Profit | (32.32 M) | 27.38 B |
| EBITDA | (55.84 M) | 3.9 B |
| Net Income | (51.7 M) | 570.98 M |
| Cash And Equivalents | 131.54 M | 2.7 B |
| Cash Per Share | 4.09 X | 5.01 X |
| Current Ratio | 13.92 X | 2.16 X |
| Book Value Per Share | 2.10 X | 1.93 K |
| Cash Flow From Operations | (49.8 M) | 971.22 M |
| Earnings Per Share | (1.74) X | 3.12 X |
| Target Price | 3.87 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.48 | -0.15 |
| Market Capitalization | 111.79 M | 19.03 B |
| Total Asset | 116.22 M | 29.47 B |
| Net Asset | 116.22 M |
Scandion Oncology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Scandion . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 10966.07 | |||
| Daily Balance Of Power | 0.2222 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.0718 | |||
| Day Typical Price | 0.0715 | |||
| Price Action Indicator | (0.0003) | |||
| Period Momentum Indicator | 0.001 |
About Scandion Oncology Buy or Sell Advice
When is the right time to buy or sell Scandion Oncology AS? Buying financial instruments such as Scandion Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Scandion Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Scandion Stock Analysis
When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.